首页> 外文期刊>International Journal of Molecular Sciences >MiR-30a-5p Inhibits Epithelial-to-Mesenchymal Transition and Upregulates Expression of Tight Junction Protein Claudin-5 in Human Upper Tract Urothelial Carcinoma Cells
【24h】

MiR-30a-5p Inhibits Epithelial-to-Mesenchymal Transition and Upregulates Expression of Tight Junction Protein Claudin-5 in Human Upper Tract Urothelial Carcinoma Cells

机译:MiR-30a-5p抑制上皮-间充质转化并上调人上尿道上皮癌细胞中紧密连接蛋白Claudin-5的表达。

获取原文
       

摘要

The involvement of microRNAs (miRNAs) in cancer development and their potential as prognostic biomarkers are becoming increasingly known. However, the signature of miRNAs and their regulatory roles in tumorigenesis of upper tract urothelial carcinoma (UTUC) remain to be elucidated. This study aimed to profile the miRNA expression pattern in UTUC tumor tissues and identify candidate miRNAs with prognostic and/or therapeutic functions. Methods and Results: We collected 22 UTUC tissue and adjacent normal tissues samples from patients who underwent nephroureterectomy. The miRNAs signatures of three selected UTUC samples using next-generation sequencing showed that miR-30a-5p was significantly downregulated in UTUC tumors compared to adjacent normal tissues. The differentially-expressed miRNAs were specifically validated by quantitative real-time polymerase chain reaction. In addition, the miRNA expression signatures were analyzed with the transcriptome profile characterized by microarray. Further in vitro studies indicated that overexpression of miR-30a-5p significantly suppressed proliferation, migration, and epithelial-to-mesenchymal transition (EMT) in cultured BFTC-909 UTUC cells . As a potential target gene of miR-30a-5p in the tight junction pathway suggested by the pathway enrichment analysis, the reduced expression of tight junction protein claudin-5 in UTUC cells was demonstrated to be upregulated by miR-30a-5p genetic delivery. Conclusions: Taken together, our findings demonstrated that miR-30a-5p inhibits proliferation, metastasis, and EMT, and upregulates the expression of tight junction claudin-5 in UTUC cells. Thus, miR-30a-5p may provide a promising therapeutic strategy for UTUC treatment.
机译:microRNA(miRNA)参与癌症发展及其作为预后生物标志物的潜力越来越为人所知。然而,miRNA的签名及其在上尿路尿路上皮癌(UTUC)的肿瘤发生中的调控作用仍有待阐明。这项研究旨在分析UTUC肿瘤组织中的miRNA表达模式,并鉴定具有预后和/或治疗功能的候选miRNA。方法和结果:我们从接受肾结直肠切除术的患者中收集了22份UTUC组织和邻近的正常组织样本。使用下一代测序技术对三个选定的UTUC样品的miRNA签名显示,与邻近的正常组织相比,UTR肿瘤中的miR-30a-5p显着下调。通过定量实时聚合酶链反应特别验证了差异表达的miRNA。另外,用以微阵列为特征的转录组谱分析了miRNA的表达特征。进一步的体外研究表明,miR-30a-5p的过表达显着抑制了培养的BFTC-909 UTUC细胞的增殖,迁移和上皮-间充质转化(EMT)。作为通路富集分析表明的紧密连接途径中miR-30a-5p的潜在靶基因,miR-30a-5p的遗传传递可证明UTUC细胞中紧密连接蛋白claudin-5的表达降低。结论:综上所述,我们的发现表明miR-30a-5p抑制UTUC细胞的增殖,转移和EMT,并上调紧密连接claudin-5的表达。因此,miR-30a-5p可能为UTUC治疗提供有希望的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号